RPV-LA (rilpivirine long-acting)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RPV-LA (rilpivirine long-acting), covering 2026-04-20 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1 [Phase 3]